BeijingWest Industries Constructs Manufacturing Greenfield, Indiana, Plant
06/27/2017
The company, a premier chassis supplier that designs and manufactures brake and suspension systems for the global automotive market, will invest more than $80 million to build and equip a new 274,369-square-foot manufacturing facility in Greenfield's Progress Park.
According to state officials, with its growth, BWI plans to begin operations in August 2019 and expects to increase its production by 4 million parts per year to meet the continued demands from its customers, which include Audi, BMW, Ferrari, Ford, General Motors, Honda and Porsche.
BWI, a joint venture of Shougang Corporation and Beijing Fangshan State-Owned Asset Management, was formed in 2009 when the company bought the brake and suspension business of Delphi Automotive, which was once a part of General Motors.
The company employs nearly 5,000 associates across more than 17 facilities around the world, which includes operations in China, Czech Republic, France, Germany, Japan, Mexico, Poland, United Kingdom and the United States.
Project Announcements
Kratos Plans Somerset County, Maryland, Production Operations
01/17/2026
CesiumAstro Expands Bee Cave, Texas, Headquarters-Manufacturing Operations
01/16/2026
Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
Solstice Advanced Materials Expands Chesterfield County, Virginia, Manufacturing Operations
01/16/2026
TransMedics Group Plans Somerville, Massachusetts, Headquarters Operations
01/16/2026
AVAIO Digital Partners Plans Pulaski County, Arkansas, Data Center Operations
01/14/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025